Everyone who rushed to get the experimental COVID-19 jabs thought life would go back to normal once they took the vaccine.
Well, not exactly.
But we tried to warn them.
In another change of the goal posts, the Pfizer CEO stated that immunity from COVID-19 after getting the second jab begins to wane after 6 months.
And you know what that means?
And more record profits for Pfizer.
It’s a win-win…..
Albert Bourla, Pfizer chairman & CEO: Covid immunity wanes 6 months after the Pfizer vaccine pic.twitter.com/wKRn1U5jjq
— Camus (@camus37) July 29, 2021
Israel is among the most vaccinated countries in the world, and they lined up first for widespread experimental COVID-19 injections.
Well, strong-armed by their government to be first.
It only makes sense that Israel will be among the first nations to start administering COVId-19 booster shots.
— FRANCE 24 English (@France24_en) July 29, 2021
Israel is recommending booster shots of the Pfizer vaccine to citizens 60 years old and older — making it the first country to offer a third dose of a Western vaccine on a wide scale.https://t.co/bqnEPt0xSZ
— NPR (@NPR) July 29, 2021
It’s textbook Big Pharma.
They don’t want to actually protect you from the disease.
And they don’t want to cure a disease.
They want lifelong customers for continuous record profits.
Profits like these:
— Swarajya (@SwarajyaMag) July 29, 2021
— Forbes (@Forbes) July 28, 2021
JUST IN – Pfizer now sees $33.5 billion in 2021 vaccine sales, up from $26 billion, and says a third dose of its #COVID19 shot "strongly" boosts protection against the Delta variant.
— Disclose.tv 🚨 (@disclosetv) July 28, 2021
CNBC sounded the alarm on the Pfizer jab’s declining efficacy:
The effectiveness of Pfizer’s Covid-19 vaccine steadily declines over time, dropping to about 84% for vaccinated people about four to six months after getting their second dose, according to CEO Albert Bourla.
The comments, made on Wednesday on CNBC’s “The Exchange,” are based on the findings of a new company-funded study that has yet to be peer reviewed. It comes as the drugmaker clashes with U.S. health officials over the need for a third Covid vaccine dose to boost immunity protection.The study found the vaccine’s effectiveness was strongest, at 96.2%, between one week and two months after receiving the second dose. It declined an average of 6% every two months, according to the study, which signed up more than 44,000 people across the U.S. and other countries. The efficacy after “four to six months was approximately 84%,” Bourla said.
“We have seen also data from Israel that there is a waning of immunity and that starts impacting what used to be what was 100% against hospitalization. Now, after the six month period, is becoming low 90s and mid-to-high 80s,” Bourla said.
“The good news is that we are very, very confident that a third dose, a booster, will take up the immune response to levels that will be enough to protect against the delta variant,” the executive added, referring to the highly contagious virus strain that’s dominant in the U.S. and other countries around the globe. It’s not uncommon for vaccines to decline in effectiveness over time, Bourla stressed, adding there’s precedent for three-dose vaccines for other diseases.
Pfizer plans to formally submit data to U.S. regulators about the benefits of a third Covid vaccine dose by mid-August, Bourla said.
How many Big Pharma customers will finally realize they’re being duped?
And how many will remain asleep and continue as lifelong customers for the Big Pharma drug cartels?